EUVIMEDEUVIMED entdecken
Crossref

Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findings from a Mexican cohort

Natalia Guajardo-Jauregui, Jesus Alberto Cardenas-de la Garza, Dionicio Angel Galarza-Delgado, Jose Ramon Azpiri-Lopez, Rosa Icela Arvizu-Rivera, Rebeca Lizeth Polina-Lugo, Iris Jazmin Colunga-Pedraza

Clinical Rheumatology · 2025

DOI: 10.1007/s10067-024-07249-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, 2025. Verfasst von Natalia Guajardo-Jauregui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Algorithms, Plaque, Atherosclerotic, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The American College of Cardiology/American Heart Association introduced the Predicting Risk of Cardiovascular EVENTs (PREVENT™) algorithm to estimate the 10-year risk of developing cardiovascular disease. We aimed to assess the cardiovascular risk (CVR) reclassification among rheumatoid arthritis (RA) patients using traditional CVR algorithms-the 2024 PREVENT™ and the 2013 Atherosclerotic Cardiovascular Disease (ASCVD)-and the presence of carotid plaque (CP). This was a cross-sectional study nested of a RA patients' cohort. A certified radiologist performed a high-resolution B-mode carotid ultrasound to identify the presence of CP. The CVR evaluation was performed by a cardiologist, blinded to carotid ultrasound results, using the PREVENT™ and the ASCVD algorithms. Cohen's kappa (k) coefficient assessed concordance between high-risk classification by CVR algorithms and CP presence. ROC curve analysis evaluated the algorithms' capacity to identify RA patients with CP. The cutoff point was determined by the Youden-Index, with p < 0.05 as statistically significant. A total of 210 RA patients were included. The reclassification of CVR due to CP was 34.3% for the PREVENT™ algorithm and 30.0% for the ASCVD algorithm. Of these, 44.4% and 71.4%, respectively, were initially classified as low risk. Concordance between CVR algorithms and carotid ultrasound showed slight agreement (k = 0.032 and k = 0.130, respectively). The PREVENT™ algorithm did not identify more than one-third of high-CVR RA patients with indication of starting statin therapy based on carotid ultrasound findings. The PREVENT™ and ASCVD algorithms showed poor performance in identifying RA patients with CP. Key Points • The presence of CP was identified in more than a third of the evaluated RA patients (35.7%), classifying them as high CVR. • CVR reclassification by the presence of CP was observed in 34.3% RA patients with the PREVENTTM algorithm and in 30.0% RA patients with the ASCVD algorithm. • Most of the reclassified patients belonged to the low-risk category, 44.4% with the PREVENTTM algorithm and 71.4% with the ASCVD algorithm. • When evaluating the concordance between the ASCVD algorithm and the carotid ultrasound for high-risk classification, a slight agreement was found (k = 0.130).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAlgorithmsPlaque, AtheroscleroticCardiovascular DiseasesCarotid Artery DiseasesAtherosclerosisHumansMaleFemaleMiddle AgedCross-Sectional StudiesAgedMexicoRisk AssessmentUltrasonographyHeart Disease Risk FactorsAdultRisk FactorsCarotid ArteriesROC Curve

Stichwörter der Autor:innen

AtherosclerosisCardiovascular diseasesCarotid ultrasoundRheumatoid arthritis

Autor:innen und Institutionen

  • Internal Medicine Department, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Rheumatology Service, Internal Medicine Department, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Cardiology Service, Internal Medicine Department, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.
  • Rheumatology Service, Internal Medicine Department, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico. iriscolunga@hotmail.com.

Zitieren

APA

Guajardo-Jauregui, N., Cardenas-de la Garza, J. A., Galarza-Delgado, D. A., Azpiri-Lopez, J. R., Arvizu-Rivera, R. I., Polina-Lugo, R. L., & Colunga-Pedraza, I. J. (2025). Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findings from a Mexican cohort. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07249-z

Vancouver

Guajardo-Jauregui N, Cardenas-de la Garza JA, Galarza-Delgado DA, Azpiri-Lopez JR, Arvizu-Rivera RI, Polina-Lugo RL, et al. Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findings from a Mexican cohort. Clinical Rheumatology. 2025. doi:10.1007/s10067-024-07249-z

BibTeX
@article{GuajardoJauregui2025,
  author = {Guajardo-Jauregui, Natalia and Cardenas-de la Garza, Jesus Alberto and Galarza-Delgado, Dionicio Angel and Azpiri-Lopez, Jose Ramon and Arvizu-Rivera, Rosa Icela and Polina-Lugo, Rebeca Lizeth and Colunga-Pedraza, Iris Jazmin},
  title = {Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findings from a Mexican cohort},
  journal = {Clinical Rheumatology},
  year = {2025},
  doi = {10.1007/s10067-024-07249-z}
}
Kostenlos starten →